已收盘 09-19 16:00:00 美东时间
+0.080
+6.72%
Gainers Conduit Pharmaceuticals (NASDAQ:CDT) stock increased by 27.4% to $0.16...
09-03 04:31
MYMD-1® development to continue through fully funded mid-stage clinical trialsClinical study of MYMD-1 in sarcopenia/frailty met primary endpoints for significantly reducing chronic inflammatory markers with
08-21 21:07
New name and stock symbol represents therapeutic focus on inhibiting TNF-alpha to regulate the immuno-metabolic system
07-24 21:07